 |
Bleomycin sulfate |
|---|---|
| Trade Name | Blenoxane |
| Orphan Indication | Malignant pleural effusion |
| USA Market Approval | USA |
| USA Designation Date | 1993-09-17 00:00:00 |
| Sponsor | Bristol-Myers Squibb Pharmaceutical Research Institute;P.O. Box 4000;Princeton, New Jersey, 08543 |
